Practical Pharmacology for Alzheimer’s Disease

by Takashi Kudo

$158.99

Account Type

Format

Quantity

Author: Takashi Kudo

Publisher: Springer

Paperback:
ISBN 10: 3319799061
ISBN 13: 978-3319799063

In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimer’s disease. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs for dementia are used.

Review

“Written by four experts in dementia research, this book describes the pharmacology of the four symptomatic drugs used in the treatment of Alzheimer's disease. It provides an overview of the basic theories of the pharmacology of Alzheimer's disease and the way in which the medications are used for the treatment of dementia. … book is most suitable for geriatric psychiatrists, geriatric medicine specialists, and neurologists who spend a significant amount of time treating people with Alzheimer's disease and other dementias.” (Danielle L. Anderson, Doody's Book Reviews, June, 2016)

From the Back Cover

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.

About the Author

Dr. Takashi Kudo, Osaka University Health Care Center, Department of Psychiatry,Toyonaka, Japan

Dr. Kenneth Davis, Mount Sinai Medical Center, New York, NY 10029, USA

Dr. Rafael Blesa Gonzalez, Autonomous University of Barcelona, Barcelona, Spain

Dr. David George Wilkinson, University of Southampton, Southampton, United Kingdom

Filters

Psychopharmacology

Practical Pharmacology for Alzheimer’s Disease